HDVY (Health Discovery) Cyclically Adjusted PS Ratio: (As of Aug. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Discovery Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Health Discovery  (OTCPK:HDVY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Health Discovery Cyclically Adjusted PS Ratio Related Terms


Health Discovery Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Health Discovery's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Discovery Cyclically Adjusted PS Ratio Chart

Health Discovery Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Health Discovery Quarterly Data
Mar16 Jun16 Sep16 Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HDVY vs SSYNF, PAXH, EWLL: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, Health Discovery's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Discovery Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Discovery's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Health Discovery's Cyclically Adjusted PS Ratio falls into.



Health Discovery Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Health Discovery's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2021 is calculated as:

For example, Health Discovery's adjusted Revenue per Share data for the three months ended in Sep. 2021 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2021 (Change)*Current CPI (Sep. 2021)
=0/274.3100*274.3100
=0.000

Current CPI (Sep. 2021) = 274.3100.

Health Discovery Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201103 0.000 223.467 0.000
201106 0.000 225.722 0.000
201109 0.000 226.889 0.000
201112 0.000 225.672 0.000
201203 0.001 229.392 0.001
201206 0.001 229.478 0.001
201209 0.003 231.407 0.004
201212 0.001 229.601 0.001
201303 0.001 232.773 0.001
201306 0.001 233.504 0.001
201309 0.001 234.149 0.001
201312 0.001 233.049 0.001
201403 0.001 236.293 0.001
201406 0.001 238.343 0.001
201409 0.001 238.031 0.001
201412 0.001 234.812 0.001
201503 0.000 236.119 0.000
201506 0.000 238.638 0.000
201509 0.000 237.945 0.000
201512 0.000 236.525 0.000
201603 0.000 238.132 0.000
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201712 0.000 246.524 0.000
201803 0.000 249.554 0.000
201806 0.000 251.989 0.000
201809 0.000 252.439 0.000
201812 0.000 251.233 0.000
201903 0.000 254.202 0.000
201906 0.003 256.143 0.003
201909 0.000 256.759 0.000
201912 0.000 256.974 0.000
202003 0.000 258.115 0.000
202006 0.000 257.797 0.000
202009 0.000 260.280 0.000
202012 0.000 260.474 0.000
202103 0.000 264.877 0.000
202106 0.000 271.696 0.000
202109 0.000 274.310 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Health Discovery Business Description

Address 2002 Summit Boulevard, NE Suite 300, Atlanta, GA, USA, 30319
Health Discovery Corp is a machine learning company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. The company operates in the field of molecular diagnostics where such tools are critical to scientific discovery. It owns a patent portfolio of machine learning technology, including certain pioneer patents on Support Vector Machine. The company recognizes revenue principally from license and royalty fees for intellectual property and from development agreements with research partners.